Press Release – New York, NY – January 23rd, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Spartan Capital Securities, LLC., acting as the exclusive placement agent, in the final closing pursuant to its previously announced private placement of Alpha Cognition, Inc. (the “Company”).
The gross proceeds of the offering received to date are US$8.45 million, which includes shares of the fully subscribed 30% overallotment.
Alpha Cognition Inc. is a biopharmaceutical company focused on providing those with neuro-degenerative diseases the support they need to function in daily life. Their recent treatment options include the impressive ALPHA-1062, a drug in testing that may prove to have a significant effect in treating Alzheimer’s Disease.
The Sichenzia Ross Ference Carmel LLP team was led by partners Gregory Sichenzia and Jeff Cahlon.
Click here for a full list of recent transactions headed by SRFC.
- Partner David Manno Quoted in AskTraders Article Discussing Barnes & Noble’s IPO Options - June 23, 2025
- Sichenzia Ross Ference Carmel LLP Represents Shuttle Pharmaceuticals in $4.25 Million Private Placement Priced at the Market Under Nasdaq Rules - June 23, 2025
- Sichenzia Ross Ference Carmel LLP Represents Revere Securities in $8 Million Public Offering of QMMM Holdings - June 23, 2025